140 related articles for article (PubMed ID: 38649902)
21. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
[TBL] [Abstract][Full Text] [Related]
22. Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer.
Schaub SK; Apisarnthanarax S; Price RG; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1339-1348. PubMed ID: 30170100
[TBL] [Abstract][Full Text] [Related]
23. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
[TBL] [Abstract][Full Text] [Related]
24. The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.
Yoon HI; Koom WS; Lee IJ; Jeong K; Chung Y; Kim JK; Lee KS; Han KH; Seong J
Liver Int; 2012 Aug; 32(7):1165-71. PubMed ID: 22435801
[TBL] [Abstract][Full Text] [Related]
25. Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child-Pugh grade B patients with locally advanced hepatocellular carcinoma.
Li JX; Zhang RJ; Qiu MQ; Yan LY; He ML; Long MY; Zhong JH; Lu HY; Zhou HM; Xiang BD; Liang SX
Radiat Oncol; 2023 Mar; 18(1):48. PubMed ID: 36890592
[TBL] [Abstract][Full Text] [Related]
26. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
[TBL] [Abstract][Full Text] [Related]
27. How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
Lee CH; Hung SP; Hong JH; Chang JT; Tsang NM; Chan KM; Tseng JH; Huang SC; Lin SM; Lien JM; Liu NJ; Lin CC; Chen WT; Chen WY; Chen PJ; Huang BS
PLoS One; 2018; 13(9):e0203854. PubMed ID: 30204800
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.
Liang SX; Zhu XD; Xu ZY; Zhu J; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):426-34. PubMed ID: 16690430
[TBL] [Abstract][Full Text] [Related]
29. Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long-term outcomes from a phase I trial.
Hong Z; Zhang W; Cai X; Yu Z; Sun J; Wang W; Lin L; Zhao J; Cheng J; Zhang G; Zhang Q; Jiang G; Wang Z
Cancer Sci; 2023 Mar; 114(3):976-983. PubMed ID: 36310409
[TBL] [Abstract][Full Text] [Related]
30. Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm).
Sun J; Zhang T; Wang J; Li W; Zhang A; He W; Zhang D; Li D; Ding J; Duan X
BMC Cancer; 2019 Aug; 19(1):846. PubMed ID: 31455251
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Hepatic Toxicity after Repeated Stereotactic Body Radiation Therapy for Recurrent Hepatocellular Carcinoma using Deformable Image Registration.
Lee S; Kim H; Ji Y; Cho B; Kim SS; Jung J; Kwak J; Park JH; Lee SW; Kim JH; Yoon SM
Sci Rep; 2018 Nov; 8(1):16224. PubMed ID: 30385839
[TBL] [Abstract][Full Text] [Related]
32. What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.
Toramatsu C; Katoh N; Shimizu S; Nihongi H; Matsuura T; Takao S; Miyamoto N; Suzuki R; Sutherland K; Kinoshita R; Onimaru R; Ishikawa M; Umegaki K; Shirato H
Radiat Oncol; 2013 Mar; 8():48. PubMed ID: 23497543
[TBL] [Abstract][Full Text] [Related]
33. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study.
Makishima H; Yasuda S; Isozaki Y; Kasuya G; Okada N; Miyazaki M; Mohamad O; Matsufuji N; Yamada S; Tsuji H; Kamada T;
Cancer Sci; 2019 Jan; 110(1):303-309. PubMed ID: 30417485
[TBL] [Abstract][Full Text] [Related]
34. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis.
Cheng JY; Liu CM; Wang YM; Hsu HC; Huang EY; Huang TT; Lee CH; Hung SP; Huang BS
Radiat Oncol; 2020 Jun; 15(1):159. PubMed ID: 32605627
[TBL] [Abstract][Full Text] [Related]
35. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
[TBL] [Abstract][Full Text] [Related]
36. Radiation-Induced Liver Toxicity.
Munoz-Schuffenegger P; Ng S; Dawson LA
Semin Radiat Oncol; 2017 Oct; 27(4):350-357. PubMed ID: 28865518
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors for Child-Pugh score elevation in hepatocellular carcinoma patients treated with conformal radiation therapy: dose-volume histogram analysis.
Yu JI; Park HC; Lim DH; Park WY
Tumori; 2013; 99(2):164-71. PubMed ID: 23748809
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced liver disease: current understanding and future perspectives.
Kim J; Jung Y
Exp Mol Med; 2017 Jul; 49(7):e359. PubMed ID: 28729640
[TBL] [Abstract][Full Text] [Related]
39. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
[TBL] [Abstract][Full Text] [Related]
40. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
